Gilead Sciences is a biopharmaceutical company, focusing on medicines to prevent and treat diseases, including HIV, viral hepatitis and cancer. Co.'s products include: Biktarvy®, which is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), an injection for intravenous use, which is a nucleotide analog RNA polymerase inhibitor indicated for certain patients for the treatment of COVID-19 requiring hospitalization; and Epclusa®, which is an oral formulation of a once-daily single tablet regimen of sofosbuvir and velpatasvir for the treatment of chronic hepatitis C virus (HCV) infection in adults and certain pediatric patients. We show 59 historical shares outstanding datapoints in our GILD shares outstanding history coverage, used to compute GILD market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing GILD market cap history over the course of time is important for investors
interested in comparing GILD's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of GILD versus a peer is one thing; comparing
GILD market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like GILD can fluctuate over the course of history.
With this page we aim to empower investors researching GILD by allowing them to research the GILD market cap history. |
Free GILD Email Alerts:
Video: The Importance of Market Cap
